The number of patients newly diagnosed with breast cancer in Korea exceeded 10,000 per annum in 2006 after a threefold increase in the decade from 1996. Westernized lifestyle, growing public concern about healthcare and prevalence of governmentally-led breast cancer screening programs are contributing to this rapid increase in newly diagnosed breast cancer.(1) The Korean Breast Cancer Society reported that the percentage of early stage breast Purpose: Sentinel lymph node (SLN) biopsy has become a standard procedure in breast cancer patient management. Accurate intraoperative assessment of metastasis of SLNs is essential for appropriate selection to avoid unnecessary axillary dissection. The aim of this study was to evaluate the performance of one-step nucleic acid amplification (OSNA) assay for detection of sentinel lymph node metastasis examination in breast cancer patients. Methods: In this study, we compared intraoperative OSNA to histological investigation with multi-level observation in 284 sentinel lymph nodes of 199 patients. Surgically obtained sentinel lymph nodes were sectioned into 2 mm intervals of up to four pieces, half of which were examined with the OSNA assay. The other half of adjacent pieces were histopathologically examined both intraoperatively and postoperatively. The presence/absence of metastases was judged by observing hematoxylin and eosin staining and cytokeratin (AE1/ AE3) immunohistochemically stained multiple slides from one lymph node. Results: Among 199 patients included, 36 cases were positive on histological examination and 34 cases were positive on OSNA assay. There were 14 discordant cases. The overall concordance with histology was 93.0% (95% confidence interval [CI], 0.86-0.96), with a sensitivity of 77.8% (95% CI, 0.61-0.90), specificity of 96.3% (95% CI, 0.92-0.99), positive predictive value of 82.4% (95% CI, 0.65-0.93) and negative predictive value of 95.2% (95% CI, 0.91-0.98). The kappa statistic analysis indicated substantial agreement of both methods, with a value of 0.76 (95% CI, 0.64-0.88). The average turnaround time was 39.0 minutes. Conclusion: The results of this study indicate that the OSNA assay has equivalent accuracy to histopathology in detecting breast cancer metastasis to lymph nodes when each method is assigned two alternate blocks of four blocks sectioned at 2 mm intervals.
In other words, axillary lymphadenectomy is of no benefit to approximately 70% to 80% of patients, and associated adverse effects such as lymphedema decrease patients' quality of life (QOL).
The sentinel lymph node (SLN) concept was introduced in breast cancer care in the 1990s to overcome concern about lymphadenectomy(2,3) and it has become a routine procedure for the surgical staging of breast cancer patients.(4) Generally, the SLN evaluation is done intraoperatively using frozen section specimens, followed by the postoperative examination of permanent sections for a confirmatory diagnosis. However, it is commonly accepted that intraoperative examination is less sensitive for detection of metastasis than postoperative examination.
The sensitivity of intraoperative SLNs examination has been reported to vary widely with a range of 44% to 95%, with most series reporting sensitivities between 60% and 75%. (5) While an intraoperative extensive SLN examination can reduce the chance of overlooking metastasis (6, 7) such examination is difficult in practice because of time restrictions and the amount of work involved.
It is recommended that lymph nodes be examined by cutting at 2 mm intervals to find evidence of macrometastasis, which is reported to negatively impact the prognosis of patients. The objective of this study was to assess the clinical utility and applicability of OSNA assay in breast cancer treatment in Korea by comparing it with histopathological examination. Lymph nodes used in the evaluation were cut into 4 pieces, at 2 mm intervals or less, and alternative blocks were provided to the two methods. Four levels (1 level for intraoperative and 3 levels for postoperative examination) of specimens were prepared from each lymph node block for histopathological examination. Next, we investigated the feasibility for implementation of OSNA assay by comparing its results with those of histopathological examination and also by assessing the turnaround time from lymph node homogenization to receiving measurement results. 
METHODS

Patients and source of lymph nodes
Study design
Resected lymph nodes were equally sectioned into blocks along their long axis at 2 mm intervals with a special cutting device ( Figure 1A ).(9) Blocks a and c were subjected to OSNA assay, and blocks b and d to intra-and postoperative histopathological examination. If lymph nodes were less than 4 mm in the short axis, they were cut in half. One half was subjected to OSNA assay, and the other half to histopathological examination. Each lymph node was subjected to OSNA assay and histopathological examination, and presence/absence of metastases for each 
Analysis of causes of discordance
To investigate, on a patient basis, discordant results between OSNA assay and histological examination, clinical information, status of non-SLNs and expression of CK19 protein in metastasis foci of lymph nodes were evaluated (Table 3) It is anticipated that OSNA assay will contribute to on the other hand, can in theory examine a larger proportion of lymph nodes, and has the potential to be the first method for assessing the volume of metastasis in lymph nodes. In this study, 14 cases of discordance were detected and on analysis most discordance was attributed to the localization of metastasis foci in a lymph node.
Since alternate blocks of the lymph node were used for OSNA and histology in this evaluation, it is self-evident that in some instances tumor deposits might have been confined to the slices analyzed by OSNA or to the blocks used for histology. The discordance of three of eight OSNA negative/histology positive discordant cases might be due to inability of OSNA assay to detect metastasis of breast cancer with low CK19 expression. Furthermore, it is known that some breast cancers do not express CK19. (9, 25) An inherent limitation of the OSNA assay is therefore that CK19 mRNA is the only target marker for metastasis detection. Some clinical institutions have started their own attempts to overcome this issue by simultaneous intraoperative imprint cytology or preoperative confir-mation of CK19 expression by core-biopsy specimen, and the establishment of an alternative assay is under discussion.
CONCLUSION
In summary, the OSNA assay proved to be a reliable and easy-to use tool for the intraoperative detection of SLN metastases in breast cancer patients at multiple institutes. Since OSNA was shown to have equivalent accuracy to in-depth, heavily used histological analyses routinely performed in Korea, its clinical usage could lead to improved diagnosis and easing of resource constraints.
We anticipate that the OSNA assay will be of great clinical significance to breast cancer treatment in Korea.
